메뉴 건너뛰기




Volumn 111, Issue 2, 2003, Pages 80-84

Endothelin-1 levels in patients with disorders of the thyroid gland

Author keywords

Endemic goiter; Endothelin 1; Graves' disease; Hashimoto's thyroiditis

Indexed keywords

ENDOTHELIN 1; THYROTROPIN; THYROXINE;

EID: 0037398620     PISSN: 09477349     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2003-39234     Document Type: Article
Times cited : (13)

References (18)
  • 4
    • 0029128672 scopus 로고
    • The role of nitric oxide and other endothelium-derived vasoactive substances in vascular disease
    • Cohen RA. The role of nitric oxide and other endothelium-derived vasoactive substances in vascular disease. Prog Cardiovasc Dis 1995; 38: 105-128
    • (1995) Prog Cardiovasc Dis , vol.38 , pp. 105-128
    • Cohen, R.A.1
  • 6
    • 0004559340 scopus 로고
    • Pressor effects of circulating endothelin are limited by its removal in the pulmonary circulation and by the release of prostacyclin and endothelium derived relaxing factor
    • De Nucci G, Thomas R, D'Orleans-Juste P, Antunes E, Walder C, Warner TD, Vane JR. Pressor effects of circulating endothelin are limited by its removal in the pulmonary circulation and by the release of prostacyclin and endothelium derived relaxing factor. Proc Natl Acad Sci USA 1988; 85: 9797-9800
    • (1988) Proc Natl Acad Sci USA , vol.85 , pp. 9797-9800
    • De Nucci, G.1    Thomas, R.2    D'Orleans-Juste, P.3    Antunes, E.4    Walder, C.5    Warner, T.D.6    Vane, J.R.7
  • 7
    • 0033659681 scopus 로고    scopus 로고
    • Endothelin in atherosclerosis: Importance of risk factors and therapeutic implications
    • D'Uscio LV, Barton M, Shaw S, Lüscher TF. Endothelin in atherosclerosis: importance of risk factors and therapeutic implications. J Cardiovasc Pharmacol 2000; 35 (Suppl 2): 55-59
    • (2000) J Cardiovasc Pharmacol , vol.35 , Issue.SUPPL. 2 , pp. 55-59
    • D'Uscio, L.V.1    Barton, M.2    Shaw, S.3    Lüscher, T.F.4
  • 9
    • 0028079673 scopus 로고
    • Phenotypic change of endothelin receptor subtype in cultured rat vascular smooth muscle cells
    • Eguchi S, Hirata Y, Imai T, Kanno K, Marumo F. Phenotypic change of endothelin receptor subtype in cultured rat vascular smooth muscle cells. Endocrinology 1994; 134: 222-228
    • (1994) Endocrinology , vol.134 , pp. 222-228
    • Eguchi, S.1    Hirata, Y.2    Imai, T.3    Kanno, K.4    Marumo, F.5
  • 10
    • 85047675323 scopus 로고
    • Why are circulating concentrations of endothelin-1 so low?
    • Frelin C, Guedin D. Why are circulating concentrations of endothelin-1 so low? Cardiovasc Res 1994; 28: 1613-1622
    • (1994) Cardiovasc Res , vol.28 , pp. 1613-1622
    • Frelin, C.1    Guedin, D.2
  • 12
    • 0029741384 scopus 로고    scopus 로고
    • Serum concentrations of basic fibroblast growth factor in collagen diseases
    • Kadono T, Kikuchi K, Kubo M, Fjimoto M, Tamaki K. Serum concentrations of basic fibroblast growth factor in collagen diseases. J Am Acad Dermatol 1996; 35: 392-397
    • (1996) J Am Acad Dermatol , vol.35 , pp. 392-397
    • Kadono, T.1    Kikuchi, K.2    Kubo, M.3    Fjimoto, M.4    Tamaki, K.5
  • 14
    • 0033978387 scopus 로고    scopus 로고
    • Chemokine-and cytokine-induced expression of endothelin-1 and endothelin-converting-enzyme I in endothelial cells
    • Molet S, Furukawa K, Maghazechi A, Hamid Q, Giaid A. Chemokine-and cytokine-induced expression of endothelin-1 and endothelin-converting-enzyme I in endothelial cells. J Allergy Clin Immunol 2000; 105: 333-338
    • (2000) J Allergy Clin Immunol , vol.105 , pp. 333-338
    • Molet, S.1    Furukawa, K.2    Maghazechi, A.3    Hamid, Q.4    Giaid, A.5
  • 15
    • 0032968208 scopus 로고    scopus 로고
    • Endothelin antagonism with bosentan: A review of potential applications
    • Roux S, Breu V, Ertel S, Clozel M. Endothelin antagonism with bosentan: a review of potential applications. J Mol Med 1999; 77: 364-376
    • (1999) J Mol Med , vol.77 , pp. 364-376
    • Roux, S.1    Breu, V.2    Ertel, S.3    Clozel, M.4


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.